Yourgene Health Plc
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a YGEN.L research report →
Companywww.yourgene-health.com
Yourgene Health Plc, a molecular diagnostic company, researches, develops, and commercializes gene analysis techniques for prenatal screening and other applications in the United Kingdom, rest of Europe, and internationally. It develops in vitro diagnostic products, such as IONA Test, a non-invasive pre-natal test (NIPT) for Down's syndrome, Edwards' syndrome, and Patau's Syndrome in pregnant women; Cystic Fibrosis Screening tests; Rapid Aneuploidy Analysis, a confirmatory diagnostic test carried out after amniocentesi; and Recurrent Pregnancy Loss, a PCR assay for the routine diagnosis of the six most common chromosomes related to pregnancy loss, as well as DPYD genotyping products. The company also offers Ranger, a technology platform for sample size selection and enrichment; Elucigene DPYD assay, a PCR test to predict a patient's response to a chemotherapy treatment; and Clarigene SARS-CoV-2 CE-IVD, a PCR assay used for routine COVID-19 testing.
- CEO
- Lyn Dafydd Rees
- IPO
- 2002
- Employees
- 253
- HQ
- Manchester, GB
Price Chart
Valuation
- Market Cap
- $16.37M
- P/E
- -1.94
- P/S
- 0.44
- P/B
- 0.11
- EV/EBITDA
- 14.28
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 56.88%
- Op Margin
- -6.76%
- Net Margin
- -5.10%
- ROE
- -5.84%
- ROIC
- -2.76%
Growth & Income
- Revenue
- $37.56M · 105.39%
- Net Income
- $-1,916,000 · 84.27%
- EPS
- $-0.00 · 84.52%
- Op Income
- $-2,540,000
- FCF YoY
- 82.39%
Performance & Tape
- 52W High
- $5.75
- 52W Low
- $0.19
- 50D MA
- $0.49
- 200D MA
- $0.50
- Beta
- 0.86
- Avg Volume
- 22.53M
Get TickerSpark's AI analysis on YGEN.L
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our YGEN.L Coverage
We haven't published any research on YGEN.L yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate YGEN.L Report →